Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_2
4
50%
Ph phase_3
3
38%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (57.1%)
Phase 33 (42.9%)

Trials by Status

active_not_recruiting113%
unknown338%
completed450%

Recent Activity

1 active trials
Showing 5 of 8
completedphase_2

Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases

NCT01643070
active_not_recruitingphase_2

TNT to Increase the Clinical Complete Response Rate for Distal LARC

NCT03840239
unknownphase_3

Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction

NCT03986385
completed

Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial

NCT02298010
unknownphase_2

Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer

NCT01952951
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01643070Phase 2

Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases

Completed
NCT03840239Phase 2

TNT to Increase the Clinical Complete Response Rate for Distal LARC

Active Not Recruiting
NCT03986385Phase 3

Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction

Unknown
NCT02298010

Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial

Completed
NCT01952951Phase 2

Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer

Unknown
NCT03038217Phase 3

Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer

Unknown
NCT00677443Phase 3

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

Completed
NCT00220116Phase 2

Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8